Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 74; no. 1; pp. 139 - 140
Main Authors Smit, Reinier, van Marum, Rob J., Péquériaux, Nathalie C., Hollander, Daan A., Bleeker, Michiel W. P., Latify, Yasamin, Hermens, Walter A., Derijks, Hieronymus J.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 2018
Springer Nature B.V
Subjects
Aged
Anticoagulants - administration & dosage
Anticoagulants - therapeutic use
Biomedical and Life Sciences
Biomedicine
Factor Xa - drug effects
Female
Glomerular Filtration Rate
Humans
Letter to the Editor
Male
Nadroparin - administration & dosage
Nadroparin - therapeutic use
Pharmacology/Toxicology
Renal Insufficiency - blood
Renal Insufficiency - drug therapy
Renal Insufficiency - physiopathology
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-2
ISSN:0031-6970
1432-1041
DOI:10.1007/s00228-017-2339-7